Sienna+MR Long-term Uptake

Completed

• Conditions: Breast Cancer Female
• Interventions: Procedure: Native 1,5 Tesla breast MRI

• Registration Number: NCT03243435
• Lead Sponsor: Kantonsspital Baden

Brief Summary

In a previous study in 2012/2013 patients were injected a superparamagnetic iron oxide for sentinel lymph node detection. In this follow up study we want to investigate how much of this tracer is still detectable.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-07
• Study First Submitted: 2016-07-05
• Primary Completion: 2017-04
• Study Completion: 2017-04
• Status Verified: 2017-08
• Study First Submitted QC: 2017-08-03
• Last Update Submitted: 2017-08-03
• Study First Posted: 2017-08-09
• Last Update Posted: 2017-08-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 34

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Native 1,5 Tesla breast MRI group	Native 1,5 Tesla breast MRI	From all patients a 1,5 Tesla MRI of the breast will be obtained

Primary Outcome Measures

Name	Time	Method
I) Analysis if the supraparamegnetic Tracer is still detectable	04/2017	Analysis by two expert radiologists

Secondary Outcome Measures

Name	Time	Method
Analysis to which degree of impairment of Imaging is detected	04/2017	Description as "no impairment", impairment, but Interpretation of Images possible", "impairment, Image Interpretation impossible"

Trial Locations

Locations (1)

Kantonsspital Baden; 🇨🇭 Baden, Aargau, Switzerland